Hologic Terminating Wisconsin Workers in MDx Relocation; Discloses Gen-Probe Revenue Contributions in Q1 | GenomeWeb

NEW YORK (GenomeWeb News) – Hologic is terminating the majority of employees in its Wisconsin molecular diagnostics operations as it consolidates that business into the San Diego facility of recently acquired Gen-Probe, it disclosed in its Form 10-Q on Thursday.

The company also said that Gen-Probe contributed more than $140 million in product sales during its fiscal first quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.